iData Insights

Peregrine Pharmaceuticals, Inc. - Product Pipeline Review – 2015 Now Available at iData Insights

News   •   Dec 01, 2015 16:16 IST

pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Peregrine Pharmaceuticals, Inc.

complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct s proprietary databases,

Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Peregrine Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Peregrine Pharmaceuticals, Inc.s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Peregrine Pharmaceuticals, Inc.s pipeline products Reasons to buy - Evaluate Peregrine Pharmaceuticals, Inc.s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Peregrine Pharmaceuticals, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Peregrine Pharmaceuticals, Inc. s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Peregrine Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Peregrine Pharmaceuticals, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Peregrine Pharmaceuticals, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues

Browse Complete Report with TOC @http://www.idatainsights.com/reports-landing-page.php?id=124231/brain-cancer-pipeline-review-h2-2015

To Get Sample Copy of Report visit @http://www.idatainsights.com/reports-landing-page.php?id=124231/brain-cancer-pipeline-review-h2-2015

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Peregrine Pharmaceuticals, Inc. Snapshot 5

Peregrine Pharmaceuticals, Inc. Overview 5

Key Information 5

Key Facts 5

Peregrine Pharmaceuticals, Inc. - Research and Development Overview 6

Key Therapeutic Areas 6

Peregrine Pharmaceuticals, Inc. - Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products - Monotherapy 9

Pipeline Products - Partnered Products 10

Partnered Products/Combination Treatment Modalities 11

Pipeline Products - Out-Licensed Products 12

Out-Licensed Products/Combination Treatment Modalities 13

Peregrine Pharmaceuticals, Inc. - Pipeline Products Glance 14

Peregrine Pharmaceuticals, Inc. - Late Stage Pipeline Products 14

Phase III Products/Combination Treatment Modalities 14

Peregrine Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 15

Phase II Products/Combination Treatment Modalities 15

Phase I Products/Combination Treatment Modalities 16

Peregrine Pharmaceuticals, Inc. - Early Stage Pipeline Products 17

Preclinical Products/Combination Treatment Modalities 17

Discovery Products/Combination Treatment Modalities 18

Peregrine Pharmaceuticals, Inc. - Drug Profiles 19

bavituximab 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

iodine I 131 derlotuximab biotin 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

PGN-632 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

Peregrine Pharmaceuticals, Inc. - Pipeline Analysis 27

Peregrine Pharmaceuticals, Inc. - Pipeline Products by Target 27

Peregrine Pharmaceuticals, Inc. - Pipeline Products by Route of Administration 28

Peregrine Pharmaceuticals, Inc. - Pipeline Products by Molecule Type 29

Peregrine Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action 30

Peregrine Pharmaceuticals, Inc. - Recent Pipeline Updates 31

Peregrine Pharmaceuticals, Inc. - Dormant Projects 41

Peregrine Pharmaceuticals, Inc. - Discontinued Pipeline Products 42

Discontinued Pipeline Product Profiles 42

bavituximab 42

Oncolym 42

Peregrine Pharmaceuticals, Inc. - Locations And Subsidiaries 43

Head Office 43

Other Locations & Subsidiaries 43

Appendix 44

Methodology 44

Coverage 44

Secondary Research 44

Primary Research 44

Expert Panel Validation 44

Contact Us 44

Disclaimer 45

Read More http://www.idatainsights.com/reports-landing-page.php?id=124231/brain-cancer-pipeline-review-h2-2015

About Us:

iData Insights which operates under Precision Research and Consulting Private Limited is a leading market research information aggregator and marketing research consulting firm. We conduct both primary and secondary research. Our work does not end with research it is also involved in distributing reports for different companies . We provide actionable recommendations and provide our expertise for business success today and tomorrow. It is our goal to be a partner to our clients in the exploration and discovery, and then be their guide in the implementation of changes that will make a difference to their bottom line.

ContactUs:
iData Insights

Tel: 1-866-237-2965

Web: http://www.idatainsights.com
Email: info@idatainsights.com

AboutiData Insights

We work around the clock until our clients are completely satisfied with their promised results. It is our mission to provide timely services coupled with acute client care to create a long-lasting relationship with you. We deliver on our promise to provide results that are essential to the success of your company. We believe that by doing so, we will earn the trust of our clients for future projects